Abstract TH283: Sex Differences in Fasting Lactate and Cardiometabolic Risk Markers
Hypertension · 2026-10 · 83 (Suppl_1)
DOI: 10.1161/hyp.83.suppl_1.th283 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hypertension, 2026-10. Verfasst von Devin Parker und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Introduction
Rates of cardiovascular and metabolic disease are rising, even among young adults. Previous studies have shown that fasting lactate is associated with blood pressure and anthropometric measures, suggesting links to cardiometabolic health. However, it remains unclear whether fasting lactate is related to vascular outcomes that may serve as early predictors of cardiometabolic disease risk and adverse events. Therefore, the purpose of this study was to establish normative fasting blood lactate concentrations in healthy young adults and determine whether lactate differed by sex and was associated with vascular function, blood pressure, and body composition.
Methods
Anthropometrics and body composition by dual-energy X-ray absorptiometry (DEXA) were assessed in 36 (n=19F) participants after an overnight fast. Venous blood samples were collected for lipid panel, fasting glucose, and lactate analyses (Lactate Plus, Nova Biomedical). Arterial stiffness was assessed by pulse wave velocity (PWV; SphygmoCor XCEL, AtCor Medical). Cutaneous microvascular endothelial function was assessed via local heating (33-39°C, 0.1°C/s), eliciting nitric oxide dependent, endothelium-dependent dilation (EDD). Skin blood flow was measured by laser-Doppler flowmetry. After obtaining EDD, local skin temperature was increased to 43°C to elicit maximal dilation. Blood flow was expressed as a percentage of maximal cutaneous vascular conductance (%CVC max ).
Results
Data are presented as means±SD. In the overall cohort (age: 24±5 y, BMI: 23.9±2.6 kg/m 2 ), fasting blood lactate (0.40-1.8 mM) positively correlates with android/gynoid fat mass distribution (AG ratio, r=0.42, p =0.01), but not with diastolic blood pressure (DBP, r=0.28, p =0.10) or predictive vascular outcomes. There was no difference in fasting blood lactate between men (0.93±0.34mM) and women (0.94±0.43mM,). When stratified by biological sex, fasting lactate (r=0.63, p ≤0.01) correlates with AG ratio, but no other variables, in men. In women, fasting lactate does not correlate with DBP or AG ratio (r=0.42, p=0.08) but correlate with maximal dilation (r=0.52, p =0.02) and PWV (r=0.46, p =0.05).
Conclusion
These findings suggest fasting blood lactate is differentially linked with cardiometabolic markers by sex, including android/gynoid fat distribution in men and microvascular dilation and arterial stiffness in women. This sex-specific pattern suggests lactate may serve as an early marker of cardiometabolic risk, though mechanisms underlying these sex differences warrant further investigation in larger cohorts.
Zitieren
APA
Parker, D., Stute, N., & Turner, C. G. (2026). Abstract TH283: Sex Differences in Fasting Lactate and Cardiometabolic Risk Markers. Hypertension, 83(Suppl_1). https://doi.org/10.1161/hyp.83.suppl_1.th283
Vancouver
Parker D, Stute N, Turner CG. Abstract TH283: Sex Differences in Fasting Lactate and Cardiometabolic Risk Markers. Hypertension. 2026;83(Suppl_1). doi:10.1161/hyp.83.suppl_1.th283
BibTeX
@article{Parker2026,
author = {Parker, Devin and Stute, Nina and Turner, Casey G},
title = {Abstract TH283: Sex Differences in Fasting Lactate and Cardiometabolic Risk Markers},
journal = {Hypertension},
year = {2026},
volume = {83},
number = {Suppl_1},
doi = {10.1161/hyp.83.suppl_1.th283}
}
EUVIMED